Centers for Disease Control and Prevention Centers for Disease Control and Prevention CDC Home Search CDC CDC Health Topics A-Z site search
National Office of Public Health Genomics
Centers for Disease Control and Prevention
Office of Genomics and Disease Prevention
Site Search
 

  Evaluation of Genetic Testing

EGAPP Stakeholders Group (ESG) Meeting

January 6–7, 2008
Houston, Texas

Meeting Agenda




MONDAY, JANUARY 7

1:00 - 1:15 PM
Meeting Introduction

Debra Leonard, Chair
Linda Bradley, CDC

1:15 - 2:00 PM
Introductions ESG Members
2:00 - 2:45 PM
Overview of EGAPP Initiative Linda Bradley
2:45 - 3:00 PM
Questions for Clarification  
3:00 - 3:15 PM
Break  
3:15 - 3:45 PM
EGAPP Working Group Overview

Celia Kaye
Chair, EWG Products SC

3:45 - 4:30 PM
Questions and Discussion  
4:30 - 5:15 PM
Small Group Discussion of Potential Roles for ESG  
5:15 - 5:45 PM

Full ESG Discussion of Potential Roles for ESG

 
5:45 - 6:00 PM
Public Comments  
6:00 - 6:30 PM
Break  
6:30 - 8:30 PM

Dinner with Presentation & Discussion

Depression / CYP450 Testing / SSRIs: Understanding the Recommendation

Questions and Discussion

Celia Kaye, EWG

 

TUESDAY, JANUARY 8

7:30 - 8:00 AM
Breakfast for ESG Members
8:00 - 9:00 AM

Recap, Discussion and Revision of Previous Day’s Points

9:00 - 9:45 AM

Stakeholder Group Discussions on the Depression / CYP450 Testing / SSRIs Recommendation

9:45 - 10:00 AM
Break
10:00 - 10:45 AM

Mixed Stakeholder Group Discussions on the Depression / CYP450 Testing / SSRIs Recommendation

10:45 - 11:15 AM

Summary of Group Discussions on Depression / CYP450 Testing / SSRIs Recommendation

11:15 - Noon
Wrap Up and Next Steps
Noon
Pick Up Lunch / Departure

Page last reviewed: January 3, 2008
Content Source: National Office of Public Health Genomics